$QGEN (Qiagen NV)

$QGEN {{ '2016-09-12T09:17:12+0000' | timeago}} • Announcement

Assay technologies provider $QGEN said it disagrees with the US District Court for the Northern District of California, San Francisco Division's decision, in which the Court granted the motion for a preliminary injunction against the company as part of a litigation filed by a competitor alleging patent infringement by $QGEN's GeneReader NGS System.

$A {{ '2018-01-19T17:03:14+0000' | timeago}} • Announcement

$A elected Dow Wilson, CEO of Varian Medical Systems Inc., to its BoD, effective March 20, 2018. Wilson is also a board member of AdvaMed, a U.S. trade association representing 80% of the medical technology firms in the U.S., and Varex Imaging Corp., which was created through the successful spin-off of Varian Medical.

$GE {{ '2018-01-17T20:56:28+0000' | timeago}} • Announcement

$GE Transportation signed two contracts, valued at over $900MM, with Kazakhstan's state-run railroad Kazakhstan Temir Zholy, as part of its long-term commitment to develop the country's railway infrastructure. The contracts include the delivery of 300 shunter locomotives and an 18-year service agreement.

$AQUA {{ '2018-01-10T13:54:54+0000' | timeago}} • Announcement

$AQUA, which provides water treatment solutions, has appointed Peter Wilver to its board of directors. Wilver, a former senior executive at $TMO, most recently served as Thermo Fisher's EVP and Chief Administrative Officer. Earlier, he held financial management roles at various industrial companies including GE, Honeywell and Grimes Aerospace.

$A {{ '2018-01-09T19:50:20+0000' | timeago}} • Announcement

$A acquired Cork, Ireland-based Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell assay kits. This acquisition expands $A's cell analysis portfolio with the addition of easy-to-use assay kits that are compatible with industry standard plate-readers.  Financial terms of the deal were not disclosed.

$TMO {{ '2018-01-09T12:43:22+0000' | timeago}} • Announcement

$TMO, a leading medical technology company, has signed an agreement with life sciences firm $ILMN, under which Thermo Fisher will provide Illumina with Ion AmpliSeq technology. The tie-up will help Illumina effectively sell Ion AmpliSeq technology to researchers engaged in scientific studies on its next-generation sequencing (NGS) platforms.

$MYGN {{ '2018-01-03T13:32:07+0000' | timeago}} • Announcement

$MYGN said $AZN will use its myChoice HRD Plus test in an exploratory analysis to identify women with advanced ovarian cancer who may benefit from maintenance treatment with Lynparza & Avastin. Under the agreement, $MYGN will use its myChoice Plus test to evaluate patients enrolled in an ongoing Phase III trial. Financial terms were not disclosed.

$JNJ {{ '2018-01-02T19:20:09+0000' | timeago}} • Announcement

$JNJ declared a cash dividend for 1Q18 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders as on Feb 27, 2018.

$CNI {{ '2017-12-22T19:58:54+0000' | timeago}} • Announcement

Railroad company $CNI has decided to purchase 200 new locomotives from $GE over the next three years. Production of the locomotives will commence next year at the GE facility in Texas, and the units are expected to be delivered in 2018, 2019 and 2020. The order includes Tier-4 and Tier -3 Evolution Series locomotives.

$JNJ {{ '2017-12-21T18:10:50+0000' | timeago}} • Announcement

Janssen Biotech, a $JNJ company, said the FDA has granted Priority Review designation for the New Drug Application (NDA) for apalutamide as treatment for non-metastatic castration-resistant prostate cancer (CRPC). This is the first agent submitted for approval to treat earlier stage castration-resistant prostate cancer at high risk for metastasis.

$GE {{ '2017-12-18T14:51:55+0000' | timeago}} • Announcement

Airborne Wireless Network (ABWN) entered into a Support Agreement on Dec. 14, 2017 with GE Aviation, one of $GE Business Units. ABWN anticipates that this relationship should significantly accelerate the development of ABWN's proprietary Hybrid Radio and Free-Optics Communications System to be demonstrated CY18.

$GE {{ '2017-12-07T15:43:43+0000' | timeago}} • Announcement

$GE Power plans to reduce its global headcount by about 12,000 positions, affecting both professional and production employees. This aligns with $GE's effort to lower overall structural costs by $3.5Bil in 2017 and 2018. The plans announced are driven by challenges in the power market worldwide.

$GE {{ '2017-12-07T15:40:27+0000' | timeago}} • Announcement

$GE Power plans to reduce its global headcount by about 12,000 positions, affecting both professional and production employees. The headcount reductions, combined with actions taken previously in 2017, will position GE Power to reach its announced target of $1Bil in structural cost reductions in 2018.

$HSKA {{ '2017-12-04T12:16:06+0000' | timeago}} • Announcement

$HSKA promoted Catherine Grassman to VP, Chief Accounting Officer and Controller following the departure of John McMahon, VP and CFO. Catherine Grassman has been Heska's Corporate Controller since January 2017.

$PX {{ '2017-12-01T18:02:19+0000' | timeago}} • Announcement

$PX and $GE's Aviation opened a new facility for their PG Technologies business, which specializes in advanced coatings that enable jet engines to withstand higher temperatures and stresses. PG Technologies is a JV between Praxair Surface Technologies Inc., a subsidiary of $PX, and GE Aviation.

$MDT {{ '2017-11-22T20:29:59+0000' | timeago}} • Webcast

In Oct., Animas announced to cease the manufacture and sale of its insulin pumps and partnered with $MDT to offer its customers the opportunity to transfer to a new device.With $JNJ exiting the insulin pump market in the US and Canada, $MDT now has access to the 90,000 patients who use Animas insulin pumps.

$TMO {{ '2017-11-22T16:06:12+0000' | timeago}} • Announcement

$TMO has received an unsolicited offer from TRC Capital to purchase up to one million shares of the company’s common stock for $181.75 per share in cash. According to Thermo Fisher, the offer price is about 4.43% lower than the closing price of its stock on November 17, 2017. The offer accounts for about 0.249% of the company’s outstanding shares.

$A {{ '2017-11-21T15:04:12+0000' | timeago}} • Webcast

For FY18, $A expects pharma to moderate down slightly from a 6% growth rate delivered in FY17. Agilent expects China to maintain a high-single-digit growth rate. For Europe and the chemical and energy markets, while Agilent experienced unexpectedly strong FY17 growth, the company cautiously guided to lower growth in FY18.

$A {{ '2017-11-20T21:43:30+0000' | timeago}} • Announcement

$A expects 1Q18 revenue of $1.145-1.165Bil. First-quarter non-GAAP earnings are expected to be in the range of $0.55 to $0.57 per share. For FY18, Agilent expects revenue of $4.72-4.74Bil and non-GAAP earnings of $2.50-2.56 per share.

$A {{ '2017-11-20T21:40:09+0000' | timeago}} • Announcement

With net revenue soaring 7% to $1.19Bil in 4Q17, $A posted a 40% jump in net income of $177MM or $0.54 per diluted share.

$GE {{ '2017-11-17T11:32:54+0000' | timeago}} • Announcement

GE Additive, a $GE company, has acquired GeonX, a privately-owned developer of simulation software. Terms of the deal, which is aimed at strengthening $GE's software simulation capabilities, were not disclosed.

Recent Transcripts

A (Agilent Technologies Inc.)
Monday, November 20 2017 - 9:30pm
INFU (InfuSystem Holdings, Inc.)
Friday, November 10 2017 - 4:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
NAVB (Navidea Biopharmaceuticals, Inc)
Wednesday, November 8 2017 - 1:30pm
NVAX (Novavax, Inc.)
Tuesday, November 7 2017 - 9:30pm
MYGN (Myriad Genetics, Inc.)
Tuesday, November 7 2017 - 9:30pm
QGEN (Qiagen NV)
Tuesday, November 7 2017 - 2:00pm
BIO.B (Bio-Rad Laboratories, Inc.)
Thursday, November 2 2017 - 9:00pm
PDLI (PDL BioPharma, Inc.)
Thursday, November 2 2017 - 8:30pm
GNMK (GenMark Diagnostics, Inc.)
Thursday, November 2 2017 - 8:30pm
HSKA (Heska Corporation)
Thursday, November 2 2017 - 3:00pm
NBIX (Neurocrine Biosciences Inc.)
Wednesday, November 1 2017 - 9:00pm
QDEL (Quidel Corp.)
Wednesday, November 1 2017 - 9:00pm
TECH (Bio-Techne Corp.)
Tuesday, October 31 2017 - 1:00pm
LH (Laboratory Corp. of America Holdings)
Wednesday, October 25 2017 - 1:00pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, October 25 2017 - 12:30pm
GE (General Electric Company)
Friday, October 20 2017 - 12:30pm
JNJ (Johnson & Johnson)
Tuesday, October 17 2017 - 12:30pm
PTN (Palatin Technologies Inc.)
Monday, September 25 2017 - 3:00pm
A (Agilent Technologies Inc.)
Tuesday, August 15 2017 - 8:30pm

AlphaGraphics you may like